{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:20:55Z","timestamp":1790371255737,"version":"4.1.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00415-016-8319-5","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T05:46:02Z","timestamp":1477287962000},"page":"2547-2548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Low testosterone and myasthenia gravis in males: a national record-linkage study"],"prefix":"10.1007","volume":"263","author":[{"given":"Julia","family":"Pakpoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raph","family":"Goldacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Goldacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"issue":"1","key":"8319_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-829593","volume":"24","author":"LH Phillips","year":"2004","unstructured":"Phillips LH (2004) The epidemiology of myasthenia gravis. Semin Neurol 24(1):17","journal-title":"Semin Neurol"},{"key":"8319_CR2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","volume":"87","author":"HA Feldman","year":"2002","unstructured":"Feldman HA, Longcope C, Derby CA et al (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589\u2013598","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"8319_CR3","first-page":"295","volume":"47","author":"C Lichiardopol","year":"2006","unstructured":"Lichiardopol C, Herlea V, Ioan V, Tomulescu V, Mixich F (2006) 46, XY hypergonadotropic hypogonadism and myasthenia gravis. Rom J Morphol Embryol 47(3):295\u2013299","journal-title":"Rom J Morphol Embryol"},{"issue":"1","key":"8319_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jnnp-2014-307932","volume":"86","author":"J Gold","year":"2015","unstructured":"Gold J, Goldacre R, Maruszak H, Giovannoni G, Yeates D, Goldacre M (2015) HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. J Neurol Neurosurg Psychiatry 86(1):9\u201312","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8319_CR5","first-page":"1","volume":"82","author":"NE Breslow","year":"1987","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. IARC Sci Publ 82:1\u2013406","journal-title":"IARC Sci Publ"},{"issue":"4","key":"8319_CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.24250","volume":"76","author":"J Pakpoor","year":"2014","unstructured":"Pakpoor J, Goldacre R, Schmierer K, Giovannoni G, Goldacre MJ (2014) Testicular hypofunction and multiple sclerosis risk: a record-linkage study. Ann Neurol 76(4):625\u2013628","journal-title":"Ann Neurol"},{"key":"8319_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3330-x","author":"J Baillargeon","year":"2016","unstructured":"Baillargeon J, Al Snih S, Raji MA et al (2016) Hypogonadism and the risk of rheumatic autoimmune disease. Clin Rheumatol. doi: 10.1007\/s10067-016-3330-x","journal-title":"Clin Rheumatol"},{"key":"8319_CR8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.nicl.2014.03.001","volume":"4","author":"F Kurth","year":"2014","unstructured":"Kurth F, Luders E, Sicotte NL, Gaser C, Giesser BS, Swerdloff RS, Montag MJ, Voskuhl RR, Mackenzie-Graham A (2014) Neuroprotective effects of testosterone treatment in men with multiple sclerosis. Neuroimage Clin 4:454\u2013460","journal-title":"Neuroimage Clin"},{"issue":"1","key":"8319_CR9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1152\/jappl.1989.66.1.498","volume":"66","author":"RC Griggs","year":"1989","unstructured":"Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D (1989) Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 66(1):498\u2013503","journal-title":"J Appl Physiol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8319-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8319-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8319-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T23:21:08Z","timestamp":1568503268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8319-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["8319"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8319-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]}}}